ABT vs PRA · P/E 25, rev $44.33B vs P/E 20, rev $1.15B
Abbott Laboratories (ABT) versus ProAssurance Corporation (PRA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
ProAssurance Corporation (PRA) is a insurance - property & casualty company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported PRA revenue for 2024-12-31 was $1.15B. Net income was $52.7M. Revenue was up 1.2% from 2023-12-31 to 2024-12-31. PRA currently screens at market cap $1.27B and trailing P/E 19.5.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. PRA currently screens at market cap $1.27B and trailing P/E 19.5.
Not investment advice. Open the ABT and PRA stock pages for the full models.
Not investment advice.